Canaccord Genuity Upgrades STAAR Surgical (STAA) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
STAAR Surgical (STAA) PT Raised to $21 at Benchmark
March 17, 2014 12:45 PM EDTBenchmark maintained a Speculative Buy rating on STAAR Surgical (NASDAQ: STAA) and raised its price target to $21.00 (from $15.00). Comments follow a favorable FDA panel vote on Toric ICL.
"There were concerns over insufficient trial data, but in the end there were five "yes"... More
STAAR Surgical (STAA) Receives Favorabl FDA Panel Vote for Visian staaTICL
March 17, 2014 6:03 AM EDTSTAAR Surgical Company (Nasdaq: STAA) reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs.
The Panel voted favorably on all three questions posed to it by the FDA's Division of Ophthalmic, Neurological and Ear,... More
